The marketing is slick, the claims are bold, and the before-and-after photos look impressive
Dosing frequency GLP-1s vary in their dosing frequency, which can significantly impact patient adherence and preference: Twice-daily: Exenatide (Byetta) Once-daily: Liraglutide (Victoza, Saxenda), Semaglutide tablets (Rybelsus) Once-weekly: Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide extended-release (Bydureon), Tirzepatide (Mounjaro, Zepbound) The once-weekly formulations generally offer greater convenience and may improve adherence
Fathizadeh, N., Ebrahimi, E., Valiani, M., Tavakoli, N., & Yar, M
S.de VilliersW